Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-May-24 5:00 PM View:  | Bersani Pietro CEO Director | Kiromic Biopharma, Inc. (KRBP) | 03-May-24 | Grant | 45,968 | -- | -- | 100% 0 to 45.97K | |
| 07-May-24 6:17 PM View: | Hungerford Brian CFO | Kiromic Biopharma, Inc. (KRBP) | 03-May-24 | Grant | 56,933 | -- | -- | 100% 0 to 56.93K | |
| 20-Mar-24 5:58 PM View: | Catlin Michael Director | Kiromic Biopharma, Inc. (KRBP) | 18-Mar-24 | Grant | 18,000 | -- | -- | 240% 7.5K to 25.5K | |
| 20-Mar-24 5:55 PM View: | Nagel Michael Director | Kiromic Biopharma, Inc. (KRBP) | 18-Mar-24 | Grant | 18,000 | -- | -- | 74% 24.3K to 42.3K | |
| 20-Mar-24 5:57 PM View: | Misajon Pamela Director | Kiromic Biopharma, Inc. (KRBP) | 18-Mar-24 | Grant | 18,000 | -- | -- | 240% 7.5K to 25.5K | |
| 15-Aug-22 4:31 PM View: | Dahlbeck Scott Chief of Staff | Kiromic Biopharma, Inc. (KRBP) | 11-Aug-22 | Grant | 50,000 | -- | -- | 11% 446.76K to 496.76K | |
| 15-Aug-22 4:23 PM View: | Bersani Pietro Chief Executive Officer Director | Kiromic Biopharma, Inc. (KRBP) | 11-Aug-22 | Grant | 638,298 | -- | -- | 100% 0 to 638.3K | |
| 15-Aug-22 4:26 PM View: | Clark Daniel Grant Chief Financial Officer | Kiromic Biopharma, Inc. (KRBP) | 11-Aug-22 | Grant | 50,000 | -- | -- | 392% 12.77K to 62.77K | |
| 25-May-22 4:15 PM View: | Dahlbeck Scott Chief Medical Officer | Kiromic Biopharma, Inc. (KRBP) | 23-May-22 | Option Exercise | 17,240 | -- | -- | 4% 429.52K to 446.76K | |
| 10-Sep-21 11:47 AM View: | Chiriva Internati Maurizio CHIEF EXECUTIVE OFFICER Director | Kiromic Biopharma, Inc. (KRBP) | 09-Sep-21 | Market Purchase | 2,800 | $3.70 | $10,357.20 | < 1% 1.38M to 1.38M | (< 1%) |
| 02-Aug-21 3:05 PM View: | Ryan Michael Charles See Remarks | Kiromic Biopharma, Inc. (KRBP) | 13-Jul-21 | Acquisition (other) | 50,189 | -- | -- | 100% 0 to 50.19K | |
| 26-May-21 3:12 PM View: | Schneider Jerry A. Director | Kiromic Biopharma, Inc. (KRBP) | 24-May-21 | Market Purchase | 5,000 | $7.31 | $36,550.00 | 100% 0 to 5.0K | 7% |
